Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data DSS, INC. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
19.2
18.7
18.5
15.6
15.4
20.3
28.4
25.9
19.1
20.8
Cost of revenue
11.1
11
11.9
12.6
16.8
37.5
Gross profit
8.06
7.65
6.66
2.95
3.45
-9.08
Research and development
0.44
0.11
0.15
0.01
0.21
1.08
1.26
1.69
0.28
0.34
Selling, general and administrative
7.33
6.47
7.09
6.67
14.7
27
25.4
51.3
38.2
12.3
Operating expenses
19.8
18.9
20.2
18.2
26.8
43.8
58.4
76.7
61.7
35.2
Operating income
-0.66
-0.23
-1.71
-2.62
-11.4
-23.5
-30
-50.8
-42.6
-14.4
Interest expense
0.25
0.22
0.14
0.2
0.13
0.55
0.28
0.27
Interest income
0.01
0.03
0.07
4.56
0.63
1.12
0.24
0.02
Other non-operating income
0
0.83
1.52
0.53
0.22
0.01
Pre-tax income
-0.94
-0.6
1.48
-2.72
0.29
-40.2
-42.7
-74
-53.7
-27.5
Income tax
0.01
-0.02
0.02
-0.13
-1.77
-4.03
0.17
0
0.01
Income from continuing operations
-2.6
2.06
-36.2
-38.2
-57.3
Net income to minority interests
-0.48
-0.92
-9.82
-16.9
-6.81
-3.56
Net income
-0.95
-0.58
1.46
-2.89
1.9
-33.1
-59.8
-60.6
-46.9
-23.9
EBITDA
0.73
1.19
-0.43
-1.47
-10.4
-19.2
-17.8
-45.6
-40.4
-11.5
EPS, basic
-0.89
-0.51
1.14
-1.39
0.63
-8.61
-6.84
-8.20
-6.63
EPS, diluted
-0.89
-0.51
1.14
-1.39
0.38
-8.61
-6.84
-8.20
-6.63
Shares, basic (weighted)
1.03
1.14
1.32
0.07
0.28
4.07
5.58
7
7.07
8.99
Shares, diluted (weighted)
1.03
1.14
1.34
0.07
0.48
4.07
5.58
7
7.7
8.99
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
5.87
4.19
2.45
1.1
5.18
56.6
16.2
6.62
11.4
6.21
Short-term investments
9.14
14.5
23.1
9.98
2.88
2.69
Receivables
1.89
2.03
2.22
4.21
3.59
5.67
5.77
3.99
3.07
2.25
Inventory
1.21
1.65
1.56
1.37
1.96
8.26
4.99
2.82
2.44
2
Other current assets
0.35
0.26
0.29
0.46
1.19
3.47
1.07
0.84
1.14
0.65
Total current assets
9.5
8.38
6.52
7.48
12.5
80.3
48
74.6
66.7
14.3
Property, plant and equipment
4.57
4.81
5.01
4.33
4.1
17.7
6.76
6.42
5.38
4.82
Lease right-of-use assets
0.14
0.18
0.5
7.76
7.21
6.47
5.83
Goodwill
2.45
2.45
2.45
2.45
26.9
56.6
60.9
26.9
1.77
1.77
Intangible assets
1.9
1.22
0.88
0.94
23.5
38.6
30.2
20.2
18.9
17
Long-term investments
0.48
0.32
2.15
9.14
13.4
23.1
9.98
6.33
6.52
Other non-current assets
0.05
0.08
0.09
0.05
0.38
0.49
1.52
0.1
0.16
0.07
Total assets
18.5
17.4
15.3
20.1
91.9
283
249
153
106
67.6
Accounts payable
2.21
0.73
1.35
1.49
1.46
1.92
5.48
3.65
2.79
2.6
Accrued liabilities
5.01
7.16
Deferred revenue
0.03
0.16
Short-term debt
1.2
0.97
0.71
0.44
0.28
3.92
47.2
47.8
Total current liabilities
7.7
9.28
5.42
4.16
8.87
27.8
73.7
55.6
65
47.5
Long-term debt
5.25
1.73
1.72
2.31
1.98
55.7
10.2
7.45
2.4
5.73
Lease liabilities
0.02
0.02
0.12
7.41
6.92
6.31
5.69
Other non-current liabilities
2.18
1.5
0.39
0.51
0.51
0.88
0.51
Total liabilities
15.2
12.6
7.7
7.84
15.4
84.5
92.2
70
73.7
58.9
Total debt
3
2.7
2.46
2.75
2.25
59.6
57.3
55.2
57.2
44.7
Paid-in capital
104
107
108
116
174
295
320
320
323
326
Retained earnings
-101
-102
-100
-103
-101
-135
-194
-256
-303
-327
Other comprehensive income
-0.05
-0.02
-0.01
Shareholders' equity
3.28
4.79
7.58
12.3
76.5
162
126
63.9
19.9
-0.83
Minority interests
3.43
36.4
31.1
19.3
12.8
9.55
Total equity
3.28
4.79
7.58
12.3
76.5
198
157
83.2
32.7
8.72
Total liabilities and equity
18.5
17.4
15.3
20.1
91.9
283
249
153
106
67.6
Shares outstanding
1.07
1.31
1.38
0.1
0.46
6.3
6.95
140
8.09
9.09
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-0.95
-0.58
1.46
-2.89
1.42
-34
-69.7
-77.5
-53.7
-27.5
Depreciation and amortization
1.39
1.41
1.28
1.15
1.07
4.32
12.2
5.21
2.24
2.89
Stock-based compensation
0.33
0.21
0.13
0.42
0.16
0.08
0
0
0.02
0.01
Deferred income tax
-0.12
-0.01
0.01
-0.13
-1.77
-4.03
0.04
Change in receivables
0.21
-0.13
-0.19
-1.66
-0.67
-2.08
-1.72
1.32
1.14
0.56
Change in inventory
-0.27
-0.44
0.09
-0.85
-0.71
-6.31
-1.55
5.48
0.38
0.15
Change in payables
0.27
-0.89
0.62
0.39
-0.18
0.46
4.22
-2.26
-0.86
-0.2
Cash from operations
5.47
-1.29
-1.38
-5.34
-6.83
-9.01
-27
-19.2
-8.76
-9.13
Capital expenditures
-0.27
-0.96
-1
-0.95
-0.32
-14.3
-1.86
-0.82
-0.13
Acquisitions
3.36
-1.88
Purchases of investments
-1.83
-9.79
-8.17
-5.37
Sales and maturities of investments
9.5
3.02
Cash from investing
0.15
-0.97
-1.1
-3.98
-10.7
-122
-18
8.94
12.1
18.1
Debt issued
1.28
60.9
1.83
4.52
Debt repaid
-1.39
-0.82
-1.19
-0.27
-0.3
-1.95
-3.36
-4.25
-2.63
-17.8
Stock issued
0.2
0.95
0.89
6.66
20.2
122
1.52
3.19
Cash from financing
-1.19
0.65
0.49
7.97
20.7
179
7.62
-2.42
1.44
-14.1
Net change in cash
-1.6
-2
-1.35
4.09
51.4
-37.3
Free cash flow
5.2
-2.25
-2.39
-6.29
-7.15
-23.3
-28.8
-20
-8.89
Interest paid
0.21
0.13
0.13
0.13
0.19
3.27
1.29
0.72
1.5
Income taxes paid
0.01
0.01
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.71 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-89.7%
Operating income / revenue.
EBITDA margin
-72.9%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-167.7%
Pre-tax income / revenue.
Net margin
-149.6%
Net income / revenue.
Operating cash flow margin
-57.8%
Cash from operations / revenue.
Return on assets (ROA)
-40.4%
Net income / average total assets.
Return on invested capital (ROIC)
-40.0%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue
68.9%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
15.7%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
16.9%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
8.7%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-9.9%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
6.2%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-104.2%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-36.5%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-35.2%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-6.0%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
16.7%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
17.2%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
80.0%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.19x
Current assets / current liabilities.
Quick ratio
0.13x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.10x
(Cash + short-term investments) / current liabilities.
Debt / assets
54.3%
Total debt / total assets.
Liabilities / assets
87.6%
Total liabilities / total assets.
Net debt
$32.0M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$1.84
Revenue / diluted weighted shares.
Operating cash flow per share
-$1.06
Cash from operations / diluted weighted shares.
Book value per share
-$0.04
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.39x
Market cap / revenue.
EV/Sales
2.12x
Enterprise value / revenue.
Earnings yield
-388.3%
Net income / market cap (the inverse of P/E).
What was DSS, INC.'s revenue in fiscal 2025?
DSS, INC. reported revenue of $20.8M for fiscal 2025, 8.7% higher than the year before.
Was DSS, INC. profitable in fiscal 2025?
No. It reported a net loss of $23.9M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.